Detalhe da pesquisa
1.
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.
Cell
; 173(7): 1755-1769.e22, 2018 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29754820
2.
Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
Int J Gynecol Pathol
; 2024 Feb 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38303106
3.
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
Int J Gynecol Cancer
; 34(4): 544-549, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38388178
4.
Endometrial cancer.
Lancet
; 399(10333): 1412-1428, 2022 04 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35397864
5.
p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk.
Mod Pathol
; 36(2): 100010, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36853783
6.
Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
Mod Pathol
; 36(6): 100145, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36828360
7.
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.
Mod Pathol
; 36(4): 100085, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36788084
8.
Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.
Histopathology
; 83(6): 880-890, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37580913
9.
Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.
Gynecol Oncol
; 175: 45-52, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37321155
10.
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.
Gynecol Oncol
; 170: 282-289, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36753816
11.
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.
J Natl Compr Canc Netw
; 21(2): 210-216, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36791751
12.
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
Int J Gynecol Pathol
; 42(4): 353-363, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36731023
13.
FIGO 2023 endometrial cancer staging: too much, too soon?
Int J Gynecol Cancer
; 2023 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37935523
14.
Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis.
J Obstet Gynaecol Can
; : 102278, 2023 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37944815
15.
Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
Cancer
; 128(15): 2853-2857, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35657171
16.
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Br J Cancer
; 127(3): 488-499, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35501389
17.
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling.
Nat Methods
; 16(10): 1007-1015, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31501550
18.
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification.
Mod Pathol
; 35(12): 1974-1982, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36241860
19.
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.
Gynecol Oncol
; 165(2): 376-384, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35504673
20.
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.
Gynecol Oncol
; 165(2): 201-214, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35246332